A Phase III, international, randomized clinical trial assessed the safety and efficacy of canagliflozin for the treatment of type 2 diabetes mellitus (T2DM) in children and adolescents.
This article was originally published on MedicalXpress.com
Phase III study supports use of canagliflozin for type 2 diabetes in children and adolescents
You may also be interested in:
The Latest
Exploring Attachment Styles and How They Affect Adult Relationships
Do you want to know more about attachment types and adult relationships? If so, you’ve come to the right place! In this blog, we’ll examine how different attachment styles impact our relationships and how understanding […]
The Latest
Why you should stop buying vitamins and get more sleep instead
Almost half of all Canadians regularly take at least one nutritional supplement such as vitamins, minerals, fibre supplements, antacids and fish oils. Many of these individuals are healthy and hoping to improve general well-being or prevent chronic […]
The Latest
Will a nutritional supplement help you run better?
Whether you jog to keep fit or compete in marathons, the physically demanding sport of running can deplete the body of essential nutrients. During a race like a half-marathon, a runner’s metabolism — or ability […]
Read More:
-
Making a smoothie, going for an evening walk, or having empathy for a loved one are all examples of executive functions that are controlled by [...]
-
A recent systematic review and meta-analysis conducted by researchers from the Research Institute of the McGill University Health Center (The Institute) and published in eClinicalMedicine [...]
-
With parents and teachers preparing for the return to classroom routines, Brock experts say fostering students’ physical and mental health is key for maximum learning [...]
